
Niranjan Sathianathen
@niranjanjs
Urology Registrar @USANZUrology
ID: 25803258
22-03-2009 10:12:01
796 Tweet
418 Followers
618 Following

Very proud to present the ARNEO study published in European Urology!! In high-risk PCa patients, neoadjuvant degarelix plus apalutamide prior to RP results in significantly improved pathological response compared to degarelix alone! steven joniau A thread🧵👇: authors.elsevier.com/c/1fow714kplrK…


Comprehensive overview of PSMA for prostate ca diagnosis Michael Hofman. Strong data from PRIMARY and more to come from PRIMARY2 GU Cast | Urology podcast! Declan Murphy #EAU23


ProtecT 15 yr: Freddie Hamdy taking on misconceptions, and conclusions. #eau23 Thoughts #pcsm??


Histologic outcomes in #activesurveillance by baseline and change in MRI Caroline Moore #eau23


Great slide on factors to predict surgical outcome for LUTS +/- need for UDS before surgery Marcus Drake #EAU23


Cutting edge presentation on the use of ICG during robotic ILND Jonathan O'Brien Nathan Lawrentschuk GU Cast | Urology podcast!. Super slick AV Declan Murphy #EAU23


Jonathan O'Brien & Declan Murphy deliver one of highest quality videos of #EAU23 with slick, professional production values. This is how all videos should be put together! If only rest of our community had skills of this group. Key message: RP is safe/feasible after #Lutectomy


Thanks to Ahmad Ozair, MD, MPH for this critical piece on limited global diversity of Cochrane Urology authorship BJU International; more work to do Vikram M. Narayan, MD @GiuliaILane Niranjan Sathianathen Dragan Ilic Onuralp Ergun Philipp Dahm Juan Franco 🏳️🌈 Imran Omar bjui-journals.onlinelibrary.wiley.com/doi/10.1111/bj…


Diagnostic Accuracy of PSMA PET/CT for Initial Staging of Intermediate to High-risk Prostate Cancer: Systematic Review and Meta-analysis "PSMA-PET should be used as a first-line approach for the initial staging of PCa." sciencedirect.com/science/articl… European Urology Declan Murphy


Cost-effectiveness of systemic treatment intensification in men with metastatic hormone-sensitive #ProstateCancer. Presented by Niranjan Sathianathen USANZ. #AUA23 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/3n9JRNh Amer. Urol. Assn.


STOPCAP meta-analysis: Docetaxel addition to ADT ➡️ limited OS/PFS benefit in low-volume metachronous mCSPC ➡️ best suited for high volume/potentially bulky/T4 primary tumors Christopher Sweeney, MBBS tombal @pgd81 Matt Sydes Nick James also on @Prof-Nick-James.bsky.social sciencedirect.com/science/articl… #ProstateCancer




Out now: Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival in BJU International by Manon Vreeburg and Oscar Brouwer #publicationoftheweek ⬇️ bit.ly/49FdYz4




🚨Neurosafe RCT(n=407) at gamechanger sess by Greg Shaw #EAU25. In men with good baseline erections having RALP, 12 mth erectile function better with neurosafe technique vs SOC (IIEF 12.7vs9.7, p<0.001) & early continence better. Published The Lancet Oncology thelancet.com/journals/lanon…


We have completed our first Robotic Retroperitoneal Lymph Node Dissection Austin Health. Patients potentially only need to stay overnight. Again we are thankful to have the Da Vinci Xi robotic system. Thank you Prof. Lawrentschuk’s proctoring and Prof. Damien Bolton’s support.
